Home > Insider Trading > Filing (0001188112-12-000340)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1080747	Greenway Medical Technologies Inc	GWAY	Services-Computer Integrated Systems Design (7373)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1540837	Neal Morrison	C/O Pamlico Capital 150 North College Street, Suite 2400 Charlotte NC 28202		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-02-07	3,441,542	$0.00	4,618,012	No	4	C	Indirect	See footnotes
Common Stock	Acquisiton	2012-02-07	666,667	$10.00	5,284,679	No	4	P	Indirect	See footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See footnotes
No	4	P	Indirect	See footnotes

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Convertible Preferred Stock	Disposition	2012-02-07	2,781,044	$0.00	2,781,044	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect

Footnotes

Shares are held by Pamlico Capital II, L.P. Mr. Morrison (the "Reporting Person") is a member of Pamlico Capital GP II, LLC, which is the general partner of, and has a one percent interest in the investments of, Pamlico Capital II, L.P.
The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein.
Each share of Series B Convertible Preferred Stock automatically converted into one share of common stock in connection with the completion of the Company's initial public offering and had no expiration date. In connection with the conversion, Pamlico Capital II, L.P. also received 660,498 shares as an additional payment in accordance with the terms of the Series B Convertible Preferred Stock.